Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Impact of delisting high-strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada.

Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T; Ontario Drug Policy Research Network.

Pharmacoepidemiol Drug Saf. 2019 Mar 14. doi: 10.1002/pds.4764. [Epub ahead of print]

PMID:
30873707
2.

The Burden of Opioid-Related Mortality in the United States.

Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

JAMA Netw Open. 2018 Jun 1;1(2):e180217. doi: 10.1001/jamanetworkopen.2018.0217.

3.

Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis.

Widdifield J, Abrahamowicz M, Paterson JM, Huang A, Thorne JC, Pope JE, Kuriya B, Beauchamp ME, Bernatsky S.

J Rheumatol. 2018 Dec 1. pii: jrheum.180427. doi: 10.3899/jrheum.180427. [Epub ahead of print]

PMID:
30504508
4.

Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study.

Muratov S, Lee J, Holbrook A, Costa A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Tarride JE.

BMC Geriatr. 2018 Nov 1;18(1):262. doi: 10.1186/s12877-018-0952-7.

5.

Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: A population-based study.

Eder L, Widdifield J, Rosen CF, Cook R, Lee KA, Alhusayen R, Paterson JM, Cheng SY, Jabbari S, Campbell W, Bernatsky S, Gladman DD, Tu K.

Arthritis Care Res (Hoboken). 2018 Sep 1. doi: 10.1002/acr.23743. [Epub ahead of print]

PMID:
30171803
6.

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

BMJ. 2018 Aug 29;362:k3207. doi: 10.1136/bmj.k3207.

7.

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN.

Ann Intern Med. 2018 Nov 20;169(10):732-734. doi: 10.7326/M18-1136. Epub 2018 Aug 21. No abstract available.

PMID:
30140853
8.

Medical Costs of Delayed Hip Fracture Surgery.

Pincus D, Wasserstein D, Ravi B, Huang A, Paterson JM, Jenkinson RJ, Kreder HJ, Nathens AB, Wodchis WP.

J Bone Joint Surg Am. 2018 Aug 15;100(16):1387-1396. doi: 10.2106/JBJS.17.01147.

PMID:
30106820
9.

Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.

Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

Drug Alcohol Depend. 2018 Oct 1;191:86-90. doi: 10.1016/j.drugalcdep.2018.06.028. Epub 2018 Jul 31.

10.

Incidence of new-onset diabetes mellitus and association with mortality in childhood solid organ transplant recipients: a population-based study.

Chanchlani R, Kim SJ, Dixon SN, Jassal V, Banh T, Borges K, Vasilevska-Ristovska J, Paterson JM, Ng V, Dipchand A, Solomon M, Hebert D, Parekh RS.

Nephrol Dial Transplant. 2019 Mar 1;34(3):524-531. doi: 10.1093/ndt/gfy213.

PMID:
30060206
11.

Reporting and evaluating wait times for urgent hip fracture surgery in Ontario, Canada.

Pincus D, Wasserstein D, Ravi B, Byrne JP, Huang A, Paterson JM, Nathens AB, Kreder HJ, Jenkinson RJ, Wodchis WP.

CMAJ. 2018 Jun 11;190(23):E702-E709. doi: 10.1503/cmaj.170830.

12.

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study.

Pasricha SV, Tadrous M, Khuu W, Juurlink DN, Mamdani MM, Paterson JM, Gomes T.

Pain. 2018 Aug;159(8):1562-1568. doi: 10.1097/j.pain.0000000000001242.

13.

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

J Addict Med. 2018 Sep/Oct;12(5):418-419. doi: 10.1097/ADM.0000000000000412. No abstract available.

14.

Causes of Death in Rheumatoid Arthritis: How Do They Compare to the General Population?

Widdifield J, Paterson JM, Huang A, Bernatsky S.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1748-1755. doi: 10.1002/acr.23548.

PMID:
29512334
15.

Risk of Hip Arthroplasty After Open Reduction Internal Fixation of a Fracture of the Acetabulum: A Matched Cohort Study.

Henry PDG, Si-Hyeong Park S, Paterson JM, Kreder HJ, Jenkinson R, Wasserstein D.

J Orthop Trauma. 2018 Mar;32(3):134-140. doi: 10.1097/BOT.0000000000001048.

PMID:
29462122
16.

Trends and uptake of new formulations of controlled-release oxycodone in Canada.

Gomes T, Jain S, Paterson JM, Sketris I, Caetano P, Henry D; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):520-525. doi: 10.1002/pds.4390. Epub 2018 Jan 23.

17.

Utilization and Short-Term Outcomes of Primary Total Hip and Knee Arthroplasty in the United States and Canada: An Analysis of New York and Ontario Administrative Data.

Cram P, Landon BE, Matelski J, Ling V, Stukel TA, Paterson JM, Gandhi R, Hawker GA, Ravi B.

Arthritis Rheumatol. 2018 Apr;70(4):547-554. doi: 10.1002/art.40407. Epub 2018 Feb 26.

PMID:
29287312
18.

Senior high-cost healthcare users' resource utilization and outcomes: a protocol of a retrospective matched cohort study in Canada.

Muratov S, Lee J, Holbrook A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Pequeno P, Costa AP, Tarride JE.

BMJ Open. 2017 Dec 26;7(12):e018488. doi: 10.1136/bmjopen-2017-018488.

19.

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants.

Gao L, Tadrous M, Knowles S, Mamdani M, Paterson JM, Juurlink D, Gomes T.

Healthc Policy. 2017 Nov;13(2):68-78.

20.

Association of Overlapping Surgery With Increased Risk for Complications Following Hip Surgery: A Population-Based, Matched Cohort Study.

Ravi B, Pincus D, Wasserstein D, Govindarajan A, Huang A, Austin PC, Jenkinson R, Henry PDG, Paterson JM, Kreder HJ.

JAMA Intern Med. 2018 Jan 1;178(1):75-83. doi: 10.1001/jamainternmed.2017.6835.

21.

Association Between Wait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery.

Pincus D, Ravi B, Wasserstein D, Huang A, Paterson JM, Nathens AB, Kreder HJ, Jenkinson RJ, Wodchis WP.

JAMA. 2017 Nov 28;318(20):1994-2003. doi: 10.1001/jama.2017.17606.

22.

Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis.

Gomes T, Mastorakos A, Paterson JM, Sketris I, Caetano P, Greaves S, Henry D; Canadian Network for Observational Drug Effect Studies Investigators.

CMAJ Open. 2017 Nov 22;5(4):E800-E807. doi: 10.9778/cmajo.20170104.

23.

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.

Jun M, Lix LM, Durand M, Dahl M, Paterson JM, Dormuth CR, Ernst P, Yao S, Renoux C, Tamim H, Wu C, Mahmud SM, Hemmelgarn BR; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

BMJ. 2017 Oct 17;359:j4323. doi: 10.1136/bmj.j4323.

24.

Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma.

Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):59-65.e2. doi: 10.1016/j.anai.2017.08.016. Epub 2017 Oct 3.

PMID:
28986124
25.

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.

Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W.

PLoS Med. 2017 Oct 3;14(10):e1002396. doi: 10.1371/journal.pmed.1002396. eCollection 2017 Oct.

26.

Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada.

Gomes T, Juurlink DN, Mamdani MM, Paterson JM, van den Brink W.

Drug Alcohol Depend. 2017 Oct 1;179:416-423. doi: 10.1016/j.drugalcdep.2017.07.008. Epub 2017 Aug 5.

PMID:
28867560
27.

Outcomes of After-Hours Hip Fracture Surgery.

Pincus D, Desai SJ, Wasserstein D, Ravi B, Paterson JM, Henry P, Kreder HJ, Jenkinson R.

J Bone Joint Surg Am. 2017 Jun 7;99(11):914-922. doi: 10.2106/JBJS.16.00788.

PMID:
28590376
28.

Lipophilic β-Blockers and Suicide in the Elderly.

Zipursky JS, Macdonald EM, Luo J, Gomes T, Mamdani MM, Paterson JM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

J Clin Psychopharmacol. 2017 Jun;37(3):381-384. doi: 10.1097/JCP.0000000000000695. No abstract available.

PMID:
28338548
29.

Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada.

Widdifield J, Ivers NM, Bernatsky S, Jaakkimainen L, Bombardier C, Thorne JC, Ahluwalia V, Paterson JM, Young J, Wing L, Tu K.

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1495-1503. doi: 10.1002/acr.23178. Epub 2017 Aug 22.

30.

Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada.

Knowles SR, Lee K, Paterson JM, Shah BR, Mamdani MM, Juurlink DN, Gomes T.

Can J Diabetes. 2017 Apr;41(2):138-142. doi: 10.1016/j.jcjd.2016.08.225. Epub 2016 Dec 15.

31.

High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study.

Fernandes K, Martins D, Juurlink D, Mamdani M, Paterson JM, Spooner L, Singh S, Gomes T.

PLoS One. 2016 Dec 14;11(12):e0167479. doi: 10.1371/journal.pone.0167479. eCollection 2016. Erratum in: PLoS One. 2017 Jan 20;12 (1):e0170834.

32.

The Cardiovascular Safety of Dutasteride.

Skeldon SC, Macdonald EM, Law MR, Huang A, Paterson JM, Mamdani MM, Juurlink D.

J Urol. 2017 May;197(5):1309-1314. doi: 10.1016/j.juro.2016.11.082. Epub 2016 Nov 16.

PMID:
27866006
33.

Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study.

Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Tu JV, Juurlink DN, Chu A, Mamdani MM.

JAMA Intern Med. 2017 Jan 1;177(1):61-66. doi: 10.1001/jamainternmed.2016.6851. Erratum in: JAMA Intern Med. 2017 Aug 1;177(8):1228.

PMID:
27820619
34.

Printed educational messages fail to increase use of thiazides as first-line medication for hypertension in primary care: a cluster randomized controlled trial [ISRCTN72772651].

Zwarenstein M, Grimshaw JM, Presseau J, Francis JJ, Godin G, Johnston M, Eccles MP, Tetroe J, Shiller SK, Croxford R, Kelsall D, Paterson JM, Austin PC, Tu K, Yun L, Hux JE.

Implement Sci. 2016 Sep 17;11(1):124. doi: 10.1186/s13012-016-0486-3.

35.

Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.

Myers MG, Kaczorowski J, Dolovich L, Tu K, Paterson JM.

Hypertension. 2016 Oct;68(4):866-72. doi: 10.1161/HYPERTENSIONAHA.116.07721. Epub 2016 Aug 15.

PMID:
27528062
36.

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Hu N, Juurlink DN, Paterson JM, Targownik LE, Turin TC, Ernst P; and the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators, Suissa S, Dormuth CR, Hemmelgarn BR, Teare GF, Caetano P, Chateau D, Henry DA, Paterson JM, LeLorier J, Levy AR, Ernst P, Platt RW, Sketris IS.

JAMA Intern Med. 2016 Oct 1;176(10):1464-1473. doi: 10.1001/jamainternmed.2016.1522.

PMID:
27479930
37.

Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis.

Oliver MJ, Al-Jaishi AA, Dixon SN, Perl J, Jain AK, Lavoie SD, Nash DM, Paterson JM, Lok CE, Quinn RR.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1606-14. doi: 10.2215/CJN.10130915. Epub 2016 Jul 27.

38.

Trends in the use and cost of antipsychotics among older adults from 2007 to 2013: a repeated cross-sectional study.

Foster PD, Camacho X, Vigod S, Yao Z, Juurlink DN, Paterson JM, Mamdani MM, Martins D, Gomes T.

CMAJ Open. 2016 Jun 10;4(2):E292-7. doi: 10.9778/cmajo.20150095. eCollection 2016 Apr-Jun.

39.

Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data.

Widdifield J, Bernatsky S, Thorne JC, Bombardier C, Jaakkimainen RL, Wing L, Paterson JM, Ivers N, Butt D, Lyddiatt A, Hofstetter C, Ahluwalia V, Tu K.

CMAJ Open. 2016 May 11;4(2):E205-12. doi: 10.9778/cmajo.20150116. eCollection 2016 Apr-Jun.

40.

Self-Monitoring of Blood Glucose Levels: Evaluating the Impact of a Policy of Quantity Limits on Test-Strip Use and Costs.

Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Juurlink DN, Singh S, Mamdani MM.

Can J Diabetes. 2016 Oct;40(5):431-435. doi: 10.1016/j.jcjd.2016.03.003. Epub 2016 May 17.

41.

Off-label use of inhaled tobramycin in Ontario, Canada.

Tadrous M, Khuu W, Paterson JM, Mamdani MM, Juurlink DN, Gomes T.

Thorax. 2016 Sep;71(9):862-4. doi: 10.1136/thoraxjnl-2015-208145. Epub 2016 May 10.

PMID:
27165985
42.

Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.

Henry D, Dormuth C, Winquist B, Carney G, Bugden S, Teare G, Lévesque LE, Bérard A, Paterson JM, Platt RW; CNODES (Canadian Network for Observational Drug Effect Studies) Investigators.

CMAJ. 2016 Jul 12;188(10):723-730. doi: 10.1503/cmaj.151243. Epub 2016 Apr 25.

43.

A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.

Filion KB, Azoulay L, Platt RW, Dahl M, Dormuth CR, Clemens KK, Hu N, Paterson JM, Targownik L, Turin TC, Udell JA, Ernst P; CNODES Investigators.

N Engl J Med. 2016 Mar 24;374(12):1145-54. doi: 10.1056/NEJMoa1506115.

44.

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Juurlink DN, Targownik LE, Turin TC, Paterson JM, Ernst P; Canadian Network for Observational Drug Effect Studies Investigators.

BMJ. 2016 Feb 17;352:i581. doi: 10.1136/bmj.i581.

45.

The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery.

Widdifield J, Moura CS, Wang Y, Abrahamowicz M, Paterson JM, Huang A, Beauchamp ME, Boire G, Fortin PR, Bessette L, Bombardier C, Hanly JG, Feldman D, Bernatsky S; CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research (CAN-AIM).

J Rheumatol. 2016 May;43(5):861-8. doi: 10.3899/jrheum.151156. Epub 2016 Feb 15.

PMID:
26879353
46.

Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis.

Juurlink DN, Gomes T, Paterson JM, Hellings C, Mamdani MM.

CMAJ Open. 2015 Nov 26;3(4):E428-31. doi: 10.9778/cmajo.20140078. eCollection 2015 Oct-Dec.

47.

Professional Pharmacy Services and Patient Complexity: An Observational Study.

Ignacy TA, Camacho X, Mamdani MM, Juurlink DN, Paterson JM, Gomes T.

J Pharm Pharm Sci. 2015;18(5):863-70.

48.

Retrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States border.

Gomes T, Paterson JM, Mukati M, Henry D; Canadian Network for Observational Drug Effect Studies investigators.

CMAJ Open. 2015 Apr 2;3(2):E231-5. doi: 10.9778/cmajo.20140103. eCollection 2015 Apr-Jun.

49.

Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study.

Antoniou T, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Garg AX, Paterson JM, Juurlink DN.

CMAJ Open. 2015 Apr 2;3(2):E166-71. doi: 10.9778/cmajo.20140074. eCollection 2015 Apr-Jun.

50.

The impact of policies to reduce blood glucose test strip utilization and costs in Canada.

Gomes T, Martins D, Cheng L, Kratzer J, Juurlink DN, Shah BR, Mamdani MM, Paterson JM, Law MR.

Can J Public Health. 2015 Apr 30;106(4):e210-6. doi: 10.17269/cjph.106.4788.

PMID:
26285192

Supplemental Content

Loading ...
Support Center